
You will be the senior marketing leader for Oxford Nanopore in the APAC Region, responsible for shaping the regional strategy for market growth, product adoption, and brand impact of our sequencing technology portfolio reporting to the VP of Marketing.
This is both a strategic, and hands-on leadership role, combining deep understanding of genomic sequencing markets with the ability to design, lead, and deliver integrated marketing programmes that accelerate commercial success in the region.
Key responsibilities:
You will be aligning global marketing strategy and initiatives with regional priorities to create a cohesive regional strategy and implementation through regionalised programs, campaigns and events, ensuring global positioning is effectively localised to meet market and customer needs.
Your role includes managing a small but effective team of regional marketing managers, regional budget, and advocating for the regional needs throughout the organisation. You will also work cross functionally with the global marketing teams (strategic and operations) and collaborate closely with regional sales and commercial leadership to ensure that marketing is a growth-engine for the region, with measurable impact on pipeline and adoption.
You will be willing to travel 30-40% primarily within the region.
Main duties:
Regional Marketing Strategic Vision → Marketing Operational Success
Team Leadership
Support Sales and Key Commercial Channels
Key requirements:
If you are looking to utilise your skills to really make a difference to humankind, then consider joining our team and apply today!
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-MW1
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.

Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.